| 1. |
Kubota Y, Kamachi K, Wakayama K, Kitamura H, Yoshihara M, Hisatomi T, Fukushima N, Ichinohe T, Sueoka E, Kimura S. Acute myeloid leukemia with t(19;21)(q13;q22) and marked eosinophilia. Ann Hematol. 2019 Jan;98(1):221-222. doi: 10.1007/s00277-018-3408-4. [Epub 2018 Jun 27] |
| 2. |
Wakamatsu M, Terakura S, Ohashi K, Fukuda T, Ozawa Y, Kanamori H, Sawa M, Uchida N, Ota S, Matsushita A, Kanda Y, Nakamae H, Ichinohe T, Kato K, Murata N, Atsuta Y, Teshima T. Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors. Blood Adv. 2019 Jan 22;3(2):105-115. doi:10.1182/bloodadvances.2018025643. |
| 3. |
Miyamura K, Yamashita T, Atsuta Y, Ichinohe T, Kato K, Uchida N, Fukuda T, Ohashi K, Ogawa H, Eto T, Inoue M, Takahashi S, Mori T, Kanamori H, Yabe H, Hama A, Okamoto S, Inamoto Y. High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation. Blood Adv. 2019 Feb 12;3(3):397-405. doi: 10.1182/bloodadvances. 2018026039. |
| 4. |
Kato K, Uike N, Wake A, Yoshimitsu M, Tobai T, Sawayama Y, Takatsuka Y, Fukuda T, Uchida N, Eto T, Nakashima Y, Kondo T, Taguchi J, Miyamoto T, Nakamae H, Ichinohe T, Kato K, Suzuki R, Utsunomiya A; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation. The outcome and characteristics of patients with relapsed adult T cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation. Hematol Oncol. 2019 Feb;37(1):54-61. doi: 10.1002/hon.2558. [EPub 2018 Sep 1.] |
| 5. |
Atsuta Y, Kato S, Morishima Y, Ohashi K, Fukuda T, Ozawa Y, Eto T, Iwato K, Uchida N, Ota S, Onizuka M, Ichinohe T, Kanda J, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Comparison of HLA Allele Mismatch and Antigen Mismatch in Unrelated Bone Marrow Transplantation in Patients with Leukemia. Biol Blood Marrow Transplant. 2019 Mar; 25(3):436-442. doi: 10.1016/j.bbmt.2018.10.002 [Epub 2018 Oct 8.] |
| 6. |
Takamatsu H, Yamashita T, Kurahashi S, Saitoh T, Kondo T, Maeda T, Nakazawa H, Murata M, Narita T, Kuroda J, Hashimoto H, Kawamura K, Miyamoto T, Honda S, Ichinohe T, Atsuta Y, Sunami K. Clinical implications of t(11;14) in patients with multiple myeloma undergoing autologous stem cell transplantation. Biol Blood Marrow Transplant. 2019 Mar;25(3):474-479. doi: 10.1016/j.bbmt.2018.11.003. [Epub 2018 Nov 10] |
| 7. |
Nakasone H, Tabuchi K, Uchida N, Ohno Y, Matsuhashi Y, Takahashi S, Onishi Y, Onizuka M, Kobayashi H, Fukuda T, Ichinohe T, Takanashi M, Kato K, Atsuta Y, Yabe H, Kanda Y. Which is more important for the selection of cord blood units for haematopoietic cell transplantation: the number of CD34-positive cells or total nucleated cells? Br J Haematol. 2019 Apr; 185(1):166-169. . doi: 10.1111/bjh.15418. [Epub 2018 May 29] |
| 8. |
Yanada M, Masuko M, Mori J, Aoki J, Mizuno S, Fukuda T, Kakihana K, Ozawa Y, Ota S, Kanamori H, Mori T, Nakamae H, Eto T, Shiratori S, Maeda T, Iwato K, Ichinohe T, Kanda Y, Tanaka J, Atsuta Y, Yano S. Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades. Bone Marrow Transplant. 2019 Apr; 54(4): 578-586. doi: 10.1038/s41409-018-0301-7. [Epub 2018 Aug 14.] |
| 9. |
Fujita N, Kobayashi R, Atsuta Y, Iwasaki F, Suzumiya J, Sasahara Y, Inoue M, Koh K, Hori T, Goto H, Ichinohe T, Hashii Y, Kato K, Suzuki R, Mitsui T. Hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma. Int J Hematol. 2019 Apr; 109(4): 483-490. doi: 10.1007/s12185-019-02608-y. [Epub 2019 Jan 30]* |
| 10. |
Honjo Y, Ichinohe T, Cellular responses to ionizing radiation change quickly over time during early development in zebrafish. Cell Biol Int. 2019 May; 43(5): 516-527. doi: 10.1002/cbin.11117. [Epub 2019 Mar 12]* |
| 11. |
Maeda Y, Ugai T, Kondo E, Ikegame K, Murata M, Uchida N, Miyamoto T, Takahashi S, Ohashi K, Nakamae H, Fukuda T, Onizuka M, Eto T, Ota S, Hirokawa M, Ichinohe T, Atsuta Y, Kanda Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome. Haematologica. 2019 May; 104(5): 1055-1061. doi: 10.3324/haematol.2018.204438. [Epub 2018 Dec 6] |
| 12. |
Kondo E, Ikeda T, Izutsu K, Chihara D, Shimizu-Koresawa R, Fujii N, Sakai T, Kondo T, Kubo K, Kato Y, Akasaka T, Fukuda T, Ichinohe T, Atsuta Y, Suzumiya J, Suzuki R; Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation. High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Data From the Japan Society for Hematopoietic Cell Transplantation Registry. Biol Blood Marrow Transplant. 2019 May; 25(5): 899-905. doi: 10.1016/j.bbmt.2019.01.020. [Epub 2019 Jan 18] |
| 13. |
Harada K, Yanada M, Machida S, Kanamori H, Onizuka M, Ozawa Y, Kobayashi H, Sawa M, Katayama Y, Ohashi K, Kanda J, Ichinohe T, Atsuta Y, Yano S. Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning. Leuk Lymphoma. 2019 Jun; 60(6):1493-1502.:1-10. doi:10.1080/10428194.2018.1535115. [Epub 2018 Nov 20] |
| 14. |
Kawahara A, Morioka T, Otani Y, Kanno K, Edahiro T, Fukushima N, Nagasaka S, Housai M, Kakimoto M, Tsuji N, Asano S, Kikuchi Y, Kobayashi T, Miyamori D, Ishida R, Kimura K, Kishikawa N, Mizooka M, Ichinohe T, Tazuma S. Successful treatment of acute chest syndrome with manual exchange transfusion in a patient with sickle beta+-thalassemia. Intern Med. 2019 Jun 1; 58(11): 1629-1634. doi: 10.2169/internalmedicine.1753-18. [Epub 2019 Feb 1] |
| 15. |
Nakasone H, Kawamura K, Yakushijin K, Shinohara A, Tanaka M, Ohashi K, Ota S, Uchida N, Fukuda T, Nakamae H, Matsuoka KI, Kanda J, Ichinohe T, Atsuta Y, Inamoto Y, Seo S, Kimura F, Ogata M. BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient. Blood Adv. 2019 Jun 11; 3(11): 1750-1760. doi: 10.1182/bloodadvances.2019000077. |
| 16. |
Harada K, Yanada M, Machida S, Kanamori H, Onizuka M, Ozawa Y, Kobayashi H, Sawa M, Katayama Y, Ohashi K, Kanda J, Ichinohe T, Atsuta Y, Yano S. Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning. Leuk Lymphoma. 2019 Jun; 60(6): 1493-1502. doi: 10.1080/10428194.2018.1535115. [Epub 2018 Nov 20] |
| 17. |
Itonaga H, Ishiyama K, Aoki K, Aoki J, Ishikawa T, Uchida N, Ohashi K, Ueda Y, Fukuda T, Sakura T, Ohno Y, Iwato K, Okumura H, Kondo T, Ichinohe T, Takanashi M, Atsuta Y, Miyazaki Y. Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60-69years with myelodysplastic syndrome. Ann Hematol. 2019 Jun; 98(6): 1367-1381. doi: 10.1007/s00277-019-03653-7. [Epub 2019 Mar 11] |
| 18. |
Fuji S, Miyamura K, Kanda Y, Fukuda T, Kobayashi T, Ozawa Y, Iwato K, Uchida N, Eto T, Ashida T, Mori T, Sawa M, Ichinohe T, Atsuta Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT. Int J Hematol. 2019 Jun; 109(6): 684-693. doi: 10.1007/s12185-019-02631-z. [Epub 2019 Mar 15] |
| 19. |
Mori T, Onishi Y, Ozawa Y, Kato C, Kai T, Kanda Y, Kurokawa M, Tanaka M, Ashida T, Sawayama Y, Fukuda T, Ichinohe T, Atsuta Y, Yamazaki H. Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with hepatitis-associated aplastic anemia. Int J Hematol. 2019 Jun; 109(6):711-717. doi: 10.1007/s12185-019-02644-8. [Epub 2019 Apr 8] |
| 20. |
Yokoyama H, Kanda J, Kato S, Kondo E, Maeda Y, Saji H, Takahashi S, Onizuka M, Onishi Y, Ozawa Y, Kanamori H, Ishikawa J, Ohno Y, Ichinohe T, Takanashi M, Kato K, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation. Bone Marrow Transplant. 2019 Jul; 54(7): 1004-1012. doi: 10.1038/s41409-018-0369-0. [Epub 2018 Nov 6] |
| 21. |
Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Uchida N, Maeda T, Mori T, Kanda Y, Kondo T, Shiratori S, Miyakoshi S, Ishiyama K, Ikegame K, Matsuhashi Y, Tanaka J, Ichinohe T, Atsuta Y, Ogata M, Suzuki R. Risk factors and predictive scoring system for post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2019 Jul; 25(7): 1441-1449. doi: 10.1016/j.bbmt.2019.02.016. [Epub 2019 Feb 20] |
| 22. |
Shimomura Y, Hara M, Tachibana T, Ohashi K, Sakura T, Fukuda T, Nakazawa H, Iwato K, Kanda Y, Ikeda T, Eto T, Kanda J, Ichinohe T, Atsuta Y, Ishikawa T, Ishiyama K. Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndrome. Br J Haematol. 2019 Jul;186(1):86-90. doi: 10.1111/bjh.15898. [Epub 2019 Apr 2] |
| 23. |
Matsumoto Y, Kobayashi T, Shimura Y, Kawata E, Nagoshi H, Ohshiro M, Sugitani M, Shimura K, Iwai T, Fuchida SI, Yoshida M, Kiyota M, Mizutani S, Chinen Y, Takimoto-Shimomura T, Nakao M, Kaneko H, Uchiyama H, Uoshima N, Nishigaki H, Kobayashi Y, Horiike S, Shimazaki C, Taniwaki M, Kuroda J; Kyoto Clinical Hematology Study Group (KOTOSG). Combined rituximab, bendamustine, and dexamethasone chemotherapy for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma: a multicenter phase II study. Int J Hematol. 2019 Jul;110(1):77-85. doi: 10.1007/s12185-019-02650-w. [Epub 2019 May 24] |
| 24. |
Harada K, Konuma T, Machida S, Mori J, Aoki J, Uchida N, Ohashi K, Fukuda T, Tanaka M, Ikegame K, Ozawa Y, Iwato K, Eto T, Onizuka M, Ichinohe T, Atsuta Y, Yano S. Risk stratification and prognosticators of acute myeloid leukemia with myelodysplasia-related changes in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 Sep; 25(9):1730-1743. doi: 10.1016/j.bbmt.2019.04.025. [EPub 2019 May 2] |
| 25. |
Yanada M, Mori J, Aoki J, Masuko M, Harada K, Uchida N, Doki N, Fukuda T, Sakura T, Kanamori H, Sawa M, Kondo T, Katayama Y, Kanda J, Ichinohe T, Atsuta Y, Yano S. Allogeneic hematopoietic stem cell transplantation for patients with a history of multiple relapses of acute myeloid leukemia. Ann Hematol. 2019 Sep;98(9):2179-2186. Doi: 10.1007/s1200277-019-03736-5. [EPub 2019 Jun 15] |
| 26. |
Kato H, Kato K, Kim SW, Fukuda T, Mori T, Sawa M, Ohno Y, Yoshioka S, Iwato K, Taji H, Onizauka M, Kurahashi S, Ichinohe T, Suzumiya J, Suzuki R. Clinical outcomes of hepatitis B or C virus infections in patients with malignant lymphoma receiving autologous stem cell transplantation; on behalf of the Adult Lymphoma Working Group of the JSHCT. Br J Haematol. 2019 Sep; 186(6):e170-e175. doi: 10.1111/bjh.16050. [EPub 2019 Jul 17] |
| 27. |
Yamasaki S, Nitta H, Kondo E, Uchida N, Miyazaki T, Ishiyama K, Kiyota M, Matsuoka H, Ichinohe T, Fukuda T, Atsuta Y, Suzumiya J, Suzuki R. Effect of allogeneic hematopoietic stem cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation. Ann Hematol. 2019 Sep;98(9):2213-2220. doi: 10.1007/s00277-019-03759-y. [EPub 2019 Jul 20] |
| 28. |
Kondo E, Shimizu-Koresawa R, Chihara D, mizuta S, Izutsu K, Ikegame K, Uchida N, fukuda T, Ichinohe T, Atsuta Y, Suzuki R; Adult Lymphoma Working Group of the JSHCT. Allogeneic haematopoietic stem cell transplantation for primary mediastinal large B-cell lymphoma patines relapsing after high dose chemotherapy with autologous stem cell transplantation: data from the Japan Society for Haematopoietic Cell Transplantation registry. Br J Haematol. 2019 Sep; 186(6):e219-e223. doi: 10.1111/bjh.16115. [EPub 2019 Jul 29] |
| 29. |
Itonaga H, Ishiyama K, Aoki K, Aoki J, Ishikawa T, Ohashi K, Fukuda T, Ozawa Y, Ota S, Uchida N, Eto T, Iwato K, Ohno Y, Takanashi M, Ichinohe T, Atsuta Y, Miyazaki Y. Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2019 Sep; 54(9): 1471-1481. doi: 10.1038/s41409-019-0469-5. [Epub 2019 Feb 4] |
| 30. |
Kato K, Mori T, Kim SW, Sawa M, Sakai T, Hashimoto H, Taguchi J, Oyake T, Kurahashi S, Imada K, Ohno H, Tanaka J, Ichinohe T, Atsuta Y, Suzuki R, Suzumiya J. Outcome of patients receiving consolidative autologous peripheral blood stem cell transplantation in the frontline treatment of intravascular large B-cell lymphoma: Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplant. 2019 Sep;54(9):1515-1517. doi: 10.1038/s41409-019-0491-7. [Epub Feb 26] |
| 31. |
Mizuno S, Kawamura K, Hanamura I, Sunami K, Mori T, Nakamura F, Iida S, Nakazawa H, Makita M, Kako S, Sawa M, Ueda Y, Takahashi H, Kanda Y, Ichinohe T, Atsuta Y, Takamatsu H, Takami A. Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agents. Bone Marrow Transplant. 2019 Oct;54(10):1595-1604. doi: 10.1038/s41409-019-0478-4. [Epub 2019 Feb 19] |
| 32. |
Kimura F, Kanda J, Ishiyama K, Yabe T, Yoshifuji K, Fukuda T, Ozawa Y, Iwato K, Eto T, Mori T, Uchida N, Ota S, Sakura T, Ichinohe T, Atsuta Y, Kanda Y; donor/source working group of the Japan Society for Hematopoietic Cell Transplantation. ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation. Bone Marrow Transplant. 2019 Oct;54(10):1676-1685. doi: 10.1038/s41409-019-0496-2. [Epub 2019 Mar 13] |
| 33. |
Akahoshi Y, Nishiwaki S, Mizuta S, Ohashi K, Uchida N, Tanaka M, Fukuda T, Ozawa Y, Takahashi S, Onizuka M, Shiratori S, Nakamae H, Kanda Y, Ichinohe T, Atsuta Y, Kako S. Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer Sci. 2019 Oct;110(10):3255-3266. doi: 10.1111/cas.14167. [EPub Aug 29] |
| 34. |
Nishiwaki S, Mizuta S, Ohashi K, Fukuda T, Uchida N, Tachibana T, Onizuka M, Ozawa Y, Onishi Y, Takahashi S, Eto T, Nakamae H, Tanaka J, Ichinohe T, Atsuta Y, Kako S. Different impact of BCR-ABL transcripts on allogeneic hematopoietic cell transplantation from different graft sources for Ph+ALL with minimal residual disease. Am J Hematol. 2019 Nov;94(11):E301-E305. doi: 10.1002/ajh.25612. [EPub Aug 26] |
| 35. |
Arai Y, Kondo T, Fuse K, Shibasaki Y, Masuko M, Sugita J, Teshima T, Uchida N, Fukuda T, Kakihana K, Ozawa Y, eto T, Tanaka M, Ikegame K, Mori T, Iwato K, Ichinohe T, Kanda Y, Atsuta Y. Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation. Blood Adv. 2019 Nov 26;3(22):3623-3634. doi: 10.1182/bloodadvances.2019000934. |
| 36. |
Yano S, Yokoyama H, Yanada M, Mori J, Aoki J, Ohashi K, Kanamori H, ozawa H, Sawa M, Nakamae H, Eto T, Ohta S, Tanaka J, Ichinohe T, Atsuta Y, Tamaki A. Role of alternative donor allogeneic hematopoietic stem cell transplantation in patients with intermediate- or poor-risk acute myeloid leukemia in first complete remission. Bone Marrow Transplant 2019 Dec;54(12):2004-2012. doi: 10.1038/s41409-019-0571-8. [EPub 2019 May 31] |
| 37. |
Kawase T, Tanaka K, Kojima H, Uchida N, Ohashi K, Fukuda T, Ozawa Y, Ikegame K, Eto T, Mori T, Miyamato T, Hidaka M, Shiratori S, Takanashi M, Atsuta Y, Ichinohe T, Kanda Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Impact of high-frequency HLA haplotypes on clinical cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2019 Dec; 25(12):2482-2489. doi: 10.1016/j.bbmt.2019.07.042. [EPub 2019 Aug 7] |
| 38. |
Ikeda T, Mori K, Kawamura K, Mori T, Hagiwara S, Ueda Y, Kahata K, Uchida N, Tsukada N, Murakami S, Yamamoto M, Takahashi T, Ichinohe T, Onizuka M, Atsuta Y, Kanda Y, Okamoto S, Sunami K, Takamatsu H. Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation. Hematol Oncol. 2019 Dec;37(5):586-594. doi: 10.1002/hon.2688. [EPub 2019 Nov 23] |
